Mr Salim Suhayl Mehio, MD | |
330 23rd Ave N, Suite 500, Nashville, TN 37203-1534 | |
(615) 342-5900 | |
(615) 342-6079 |
Full Name | Mr Salim Suhayl Mehio |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 35 Years |
Location | 330 23rd Ave N, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427043645 | NPI | - | NPPES |
3868838 | Medicaid | TN | |
64042229 | Medicaid | KY | |
64042229 | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 35713 (Tennessee) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 35713 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tristar Centennial Medical Center | Nashville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Columbia Medical Group - The Frist Clinic Inc | 7517854508 | 51 |
News Archive
The studies in JAMA Internal Medicine look at issues surrounding coordinated care between doctors and their patients.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
Ventas, Inc. ("Ventas" or the "Company") said today that third quarter 2009 normalized Funds From Operations ("FFO") increased 7.4 percent to $103.4 million, from $96.2 million for the comparable 2008 period. Normalized FFO per diluted common share was $0.66 in the third quarter of 2009, compared to $0.68 in the comparable 2008 period. Weighted average diluted shares outstanding in the third quarter of 2009 were 156.5 million, compared to 141.1 million in the comparable 2008 period.
Taking time for leisure activities apart from the demands of work and other responsibilities helps people function better physically and mentally. In fact, the more time spent doing different types of enjoyable activities, the better a person's health tends to be, according to a new study.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 3 days ago
Entity Name | Columbia Medical Group - The Frist Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679560023 PECOS PAC ID: 7517854508 Enrollment ID: O20040303000956 |
News Archive
The studies in JAMA Internal Medicine look at issues surrounding coordinated care between doctors and their patients.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
Ventas, Inc. ("Ventas" or the "Company") said today that third quarter 2009 normalized Funds From Operations ("FFO") increased 7.4 percent to $103.4 million, from $96.2 million for the comparable 2008 period. Normalized FFO per diluted common share was $0.66 in the third quarter of 2009, compared to $0.68 in the comparable 2008 period. Weighted average diluted shares outstanding in the third quarter of 2009 were 156.5 million, compared to 141.1 million in the comparable 2008 period.
Taking time for leisure activities apart from the demands of work and other responsibilities helps people function better physically and mentally. In fact, the more time spent doing different types of enjoyable activities, the better a person's health tends to be, according to a new study.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Salim Suhayl Mehio, MD 330 23rd Ave N, Suite 500, Nashville, TN 37203-1534 Ph: (615) 342-5900 | Mr Salim Suhayl Mehio, MD 330 23rd Ave N, Suite 500, Nashville, TN 37203-1534 Ph: (615) 342-5900 |
News Archive
The studies in JAMA Internal Medicine look at issues surrounding coordinated care between doctors and their patients.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
Ventas, Inc. ("Ventas" or the "Company") said today that third quarter 2009 normalized Funds From Operations ("FFO") increased 7.4 percent to $103.4 million, from $96.2 million for the comparable 2008 period. Normalized FFO per diluted common share was $0.66 in the third quarter of 2009, compared to $0.68 in the comparable 2008 period. Weighted average diluted shares outstanding in the third quarter of 2009 were 156.5 million, compared to 141.1 million in the comparable 2008 period.
Taking time for leisure activities apart from the demands of work and other responsibilities helps people function better physically and mentally. In fact, the more time spent doing different types of enjoyable activities, the better a person's health tends to be, according to a new study.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 3 days ago
Megan Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |